1. Emerging drugs for prostate cancer. (December 2013) Authors: Chung, Paul H; Gayed, Bishoy A; Thoreson, Gregory R; Raj, Ganesh V Journal: Expert opinion on emerging drugs Issue: Volume 18:Number 4(2013:Dec.) Page Start: 533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview. Issue 2 (February 2021) Authors: Blatt, Eliot B; Kopplin, Noa; Kumar, Shourya; Mu, Ping; Conzen, Suzanne D; Raj, Ganesh V Journal: Endocrine-related cancer Issue: Volume 28:Issue 2(2021) Page Start: R31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PARP‐1 regulates DNA repair factor availability. Issue 12 (22nd November 2018) Authors: Schiewer, Matthew J; Mandigo, Amy C; Gordon, Nicolas; Huang, Fangjin; Gaur, Sanchaika; de Leeuw, Renée; Zhao, Shuang G; Evans, Joseph; Han, Sumin; Parsons, Theodore; Birbe, Ruth; McCue, Peter; McNair, Christopher; Chand, Saswati N; Cendon‐Florez, Ylenia; Gallagher, Peter; McCann, Jennifer J; Poud... Journal: EMBO molecular medicine Issue: Volume 10:Issue 12(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC. Issue 2 (20th February 2022) Authors: Lee, Cheng‐Fan; Chen, Yu‐An; Hernandez, Elizabeth; Pong, Rey‐Chen; Ma, Shihong; Hofstad, Mia; Kapur, Payal; Zhau, Haiyen; Chung, Leland WK; Lai, Chih‐Ho; Lin, Ho; Lee, Ming‐Shyue; Raj, Ganesh V; Hsieh, Jer‐Tsong Journal: Clinical and translational medicine Issue: Volume 12:Issue 2(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗